David A. Siegel Opiant Pharmaceuticals, Inc. Transaction History

Two Sigma Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$9.38 - $20.29 $45,024 - $97,392	-4,800 Reduced 20.51%	18,600 $377,000
Q3 2022 Nov 14, 2022	SELL	$9.52 - $13.48 $485,520 - $687,480	-51,000 Reduced 68.55%	23,400 $252,000
Q2 2022 Aug 15, 2022	BUY	$10.12 - $23.32 $17,204 - $39,644	1,700 Added 2.34%	74,400 $892,000
Q1 2022 May 16, 2022	SELL	$19.54 - $33.59 $189,538 - $325,823	-9,700 Reduced 11.77%	72,700 $1.56 Million
Q4 2021 Feb 14, 2022	SELL	$22.51 - $36.79 $15,757 - $25,753	-700 Reduced 0.84%	82,400 $2.77 Million
Q3 2021 Nov 15, 2021	BUY	$13.28 - $25.79 $1.1 Million - $2.14 Million	83,100 New	83,100 $2.14 Million

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.